Showing Results for: “diabetes exercise”

Improvements in Vision Impairment and Diabetes Plateaued in the Last Decade A Centers for Disease Control and Prevention (CDC) study provides new insights into vision impairment (VI) prevalence over the last 20 years. The findings demonstrate that declines in VI among adults with diabetes seen in the first decade of the 2000s may have plateaued in 2012. The findings were presented at the 82nd Scientific Sessions of the American Diabetes Association ® (ADA) in New Orleans, LA. Diabetic retinopathy is a common and serious complication of diabetes that occurs when blood vessels in the retina are

Today, the American Diabetes Association ® (ADA) published important updates to the Standards of Medical Care in Diabetes—2022 (Standards of Care) , in annotations as the Living Standards of Care . Changes include new data on: Finerenone and its effects in people with type 2 diabetes and chronic kidney disease on cardiovascular outcome SGLT2 inhibitors and their effects in people with type 2 diabetes on heart failure and renal outcomes New information on calculating eGFR and inclusion of race for kidney disease diagnosis These amendments were driven by recently published research and were

CEO Tracey D. Brown Calls on Congress to Take Aggressive Steps to Make Insulin and Other Diabetes Medications More Affordable The American Diabetes Association® (ADA) last week recommended urgent federal action to bring down skyrocketing drug prices before the Senate Health, Education, Labor and Pensions (HELP) Committee. In a statement for the congressional record submitted in conjunction with the HELP Committee’s Primary Health and Retirement Security Subcommittee’s recent hearing exploring reasons the U.S. pays the highest prices in the world for prescription medications, ADA CEO Tracey D

As part of the Biden administration’s plan to review Trump executive actions on health care, the U.S. Department of Health and Human Services (HHS) announced a delay in implementation of the “rebate rule,” moving the effective date from January 1, 2022, to January 1, 2023. The Trump administration announced its rebate proposal in 2018. The proposed rule would have effectively banned the rebates drug manufacturers give to pharmacy benefit managers in Medicare Part D—Medicare’s prescription drug program—only allowing rebates at the point of sale in an effort to reduce patients’ out-of-pocket

Last night Congress took an important step toward COVID-19 management and recovery, addressing health disparities and funding crucial diabetes research programs. The diabetes community has been disproportionately affected by this pandemic, and the American Diabetes Association® (ADA) is pleased that Americans with diabetes will soon see some relief during these difficult and extraordinary times. Although there’s still much more to be done to support those facing a heightened risk during this unprecedented public health and economic crisis – including ensuring continuity of health insurance

Keeping our young people healthy and active amid coronavirus related closures is essential, and while organizations continue to scramble and pivot, the American Diabetes Association® (ADA) has transformed Project Power virtually. Project Power is a free at-home online experience consisting of fun lessons and physical activity challenges, which encourages children and families to stay healthy together. Nearly 1 in 3 children in the United States are overweight or obese. Through the initiative, the ADA intends to slow the trajectory of childhood obesity by focusing on health promotion, nutrition

Diabetes isn’t going anywhere, so let’s work together and do our part. What exactly does that mean? During the month of November, the American Diabetes Association® (ADA) will educate everyone on diabetes and its complications by showcasing simple steps that can be taken to recognize, reduce risks, and ease the burden of diabetes. According to the Centers for Disease Control and Prevention, 40% of people who passed away from Covid-19 were living with diabetes. Now it is time to act and take necessary steps, collectively, to turn our post-COVID reality into a proclamation for better health and

Waters Bill Would Eliminate Cost-Sharing for Insulin-Dependent Seniors The American Diabetes Association (ADA), announced its strong support today for the Affordable Insulin for the COVID-19 Emergency Act, introduced by Representative Maxine Waters (D-CA-43). The ADA called on all Members of Congress to join the measure’s 25 original co-sponsors. The bill ensures that insulin-dependent Medicare beneficiaries are able to obtain their prescriptions for insulin and associated medical supplies with no copayments, coinsurance, deductibles or other cost-sharing for the duration of the COVID-19

The American Heart Association and the American Diabetes Association share inspiration from patients and need-to-know information from experts As emerging science around COVID-19 highlights elevated danger for people with diabetes, heart disease and stroke 1 , the American Heart Association and the American Diabetes Association urge people living with type 2 diabetes and/or cardiovascular disease to manage their conditions and look for unique opportunities to double-down on their health goals during the pandemic. Brandon Lewis of Dallas lives with diabetes, and now is dealing with being at

New Platform will Empower the 30 Million Americans with Diabetes to Advocate for Legislation that Promotes Insulin and Drug Affordability The American Diabetes Association (ADA) has created a free Communications & Engagement Platform to demystify the political rhetoric of drug pricing policy for the diabetes community. In keeping with ADA’s commitment to help those living with diabetes thrive, this platform will enable people with diabetes, their families and their health care providers to easily understand the legislative options on the table using three simple questions. It is critical that